Back to UBS Group AG UBS Group AG

SAVASAVA
Showing 8 of 30 quarters

Position history for UBS Group AGUBS Group AG's holdings in FILANA THERAPEUTICS INC

UBS Group AG holds 39,062 shares of SAVA (FILANA THERAPEUTICS INC), worth $46,484 as of 2026-Q2. The position was increased (+236.7% shares).

Current Value

$46,484

Current Shares

39,062

Total Value Change

-$2.6M

Total Shares Change

-49,811

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
39,062
+236.7%
$46,4840.0%$2.22
22
2026-Q1
Decreased
11,603
-61.1%
$19,6090.0%$2.22
0
2025-Q4
Decreased
29,869
-84.2%
$59,1400.0%$2.03
0
2025-Q3
Decreased
188,993
-0.6%
$549,9700.0%$3.14
0
2025-Q2
Decreased
190,085
-65.2%
$344,0540.0%$1.75
0
2025-Q1
Decreased
545,815
-41.4%
$818,7230.0%$1.65
0
2024-Q4
Increased
930,726
+947.3%
$2.2M0.0%$2.40
42
2024-Q3
Increased
88,873
+41.0%
$2.6M0.0%$28.49
35

Other major holders of SAVA: BNP PARIBAS FINANCIAL MARKETS, VANGUARD GROUP INC, BlackRock Finance, Inc., GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used